PGE1
Indications
Information about indications was extracted from the indications and usage sections of the labels.
| Side effects: | 40 |
| Source: | Medsafe |
|---|
| Side effects: | 42 |
| Source: | FDA Structured Product Label |
|---|
| Side effects: | 52 |
| Source: | Health Canada |
|---|
| Side effects: | 52 |
| Source: | medicines.org.au |
|---|
| Side effects: | 21 |
| Source: | FDA Structured Product Label |
|---|
| Side effects: | 33 |
| Source: | FDA Structured Product Label |
|---|
| Side effects: | 47 |
| Source: | Medsafe |
|---|
| Side effects: | 60 |
| Source: | FDA Structured Product Label |
|---|
| Side effects: | 63 |
| Source: | FDA Structured Product Label |
|---|
| Side effects: | 83 |
| Source: | Health Canada |
|---|
Color scheme:
standard – alternative
|
|
|
100%
|
|
|
|
75%
|
|
|
|
50%
|
|
|
|
10%
|
|
|
|
frequent (1% to 100%)
|
|
|
|
infrequent (0.1% to 1%)
|
|
|
|
rare (<0.1%)
|
|
|
|
postmarketing
|
|
|
|
0%
|
|
|
|
no frequency information
|
|
|
|
not found on label
|